220 related articles for article (PubMed ID: 15785372)
21. Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation.
Gonzalez-Stawinski GV; Daggett CW; Lau CL; Karoor S; Love SD; Logan JS; Gaca JG; Parker W; Davis RD
J Am Coll Surg; 2002 Jun; 194(6):765-73. PubMed ID: 12081067
[TBL] [Abstract][Full Text] [Related]
22. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo lung model of pig-to-human hyperacute xenograft rejection.
Macchiarini P; Mazmanian GM; Oriol R; de Montpreville V; Dulmet E; Fattal S; Libert JM; Doubine S; Nochy D; Rieben R; Dartevelle P
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):315-25. PubMed ID: 9305182
[TBL] [Abstract][Full Text] [Related]
24. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
Pfeiffer S; Zorn GL; Zhang JP; Giorgio TD; Robson SC; Azimzadeh AM; Pierson RN
Transplantation; 2003 Apr; 75(7):953-9. PubMed ID: 12698079
[TBL] [Abstract][Full Text] [Related]
25. Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models.
Fiorante P; Banz Y; Mohacsi PJ; Kappeler A; Wuillemin WA; Macchiarini P; Roos A; Daha MR; Schaffner T; Haeberli A; Mazmanian GM; Rieben R
Xenotransplantation; 2001 Feb; 8(1):24-35. PubMed ID: 11208188
[TBL] [Abstract][Full Text] [Related]
26. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
[TBL] [Abstract][Full Text] [Related]
27. Potential of an injectable polymer to prevent hyperacute rejection of ex vivo perfused porcine lungs.
Wiebe K; Oezkur M; Pöling J; Haverich A
Transplantation; 2006 Sep; 82(5):681-8. PubMed ID: 16969293
[TBL] [Abstract][Full Text] [Related]
28. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
[TBL] [Abstract][Full Text] [Related]
29. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors.
Schuurman HJ; Pino-Chavez G; Phillips MJ; Thomas L; White DJ; Cozzi E
Transplantation; 2002 Apr; 73(7):1146-51. PubMed ID: 11965048
[TBL] [Abstract][Full Text] [Related]
30. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
[TBL] [Abstract][Full Text] [Related]
31. Role of anti-Gal alpha13Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood.
Pfeiffer S; Zorn GL; Kelishadi S; Oriol R; Wolf P; Pierson RN; Azimzadeh AM
Ann Thorac Surg; 2001 Nov; 72(5):1681-9; discussion 1690. PubMed ID: 11722065
[TBL] [Abstract][Full Text] [Related]
32. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
[TBL] [Abstract][Full Text] [Related]
33. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts.
Pruitt SK; Kirk AD; Bollinger RR; Marsh HC; Collins BH; Levin JL; Mault JR; Heinle JS; Ibrahim S; Rudolph AR
Transplantation; 1994 Feb; 57(3):363-70. PubMed ID: 8108871
[TBL] [Abstract][Full Text] [Related]
34. Human complement regulatory proteins protect swine lungs from xenogeneic injury.
Yeatman M; Daggett CW; Lau CL; Byrne GW; Logan JS; Platt JL; Davis RD
Ann Thorac Surg; 1999 Mar; 67(3):769-75. PubMed ID: 10215226
[TBL] [Abstract][Full Text] [Related]
35. Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation.
Kulick DM; Salerno CT; Dalmasso AP; Park SJ; Paz MG; Fodor WL; Bolman RM
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):690-9. PubMed ID: 10733757
[TBL] [Abstract][Full Text] [Related]
36. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.
Yeatman M; Daggett CW; Parker W; Byrne GW; Logan JS; Platt JL; Davis RD
Transplantation; 1998 Apr; 65(8):1084-93. PubMed ID: 9583870
[TBL] [Abstract][Full Text] [Related]
37. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
38. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
[TBL] [Abstract][Full Text] [Related]
39. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts.
Kaplon RJ; Michler RE; Xu H; Kwiatkowski PA; Edwards NM; Platt JL
Transplantation; 1995 Jan; 59(1):1-6. PubMed ID: 7839407
[TBL] [Abstract][Full Text] [Related]
40. Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.
Collins BJ; Blum MG; Parker RE; Chang AC; Blair KS; Zorn GL; Christman BW; Pierson RN
J Appl Physiol (1985); 2001 Jun; 90(6):2257-68. PubMed ID: 11356791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
